/R E P E A T -- MEDIA INVITE - Mila holds a world-class conference on AI and Human Rights with the United Nations, the OECD, and UNESCO among others/
MONTRÉAL, Feb. 9, 2024 /CNW/ - Mila - Quebec Artificial Intelligence Institute invites media representatives to a world-class conference that focuses on the critical efforts needed to incorporate human rights into artificial intelligence (AI) governance mechanisms. This event will take place from February 14 to 16, 2024, in Montreal.
Mila is convening top officials from the United Nations, the OECD, UNESCO, and leading experts from academia, civil society and industry to discuss the intersection of human rights and AI governance, for the first time as part of an official event.
WHAT
Conference Protecting Human Rights in the Age of AI
WHEN
February 14 to 16, 2024
WHERE
Mila's Agora, 6650 Saint-Urbain Street, Montréal
Webcast available on February 14 only (link will be provided upon request)
The agenda highlights suggest that the opening day and the latter half of the second day will be of particular interest to members of the press. The full program is available here. (Note: all times local, EST)
DAY 1 ? FEBRUARY 14, 2024:
5:00 p.m.: Welcome ? by Valérie Pisano, President and CEO, Mila
5:10 p.m.: Opening remarks ? by Amandeep Singh Gill, United Nations Under-Secretary-General and Tech Envoy
5:25 p.m.: Keynote How relevant are human rights in the age of AI ? by Alondra Nelson, Harold F. Linder Professor at the Institute for Advanced Study and former Acting Director of the White House Office of Science and Technology Policy and former Deputy Assistant to US President Joe Biden
5:50 p.m.: Panel discussion ? with Yoshua Bengio, Full Professor, Université de Montréal and Founder and Scientific Director, Mila, Alondra Nelson & Amandeep Singh Gill
DAY 2 ? FEBRUARY 15, 2024. Highlights include:
10:15 a.m.: Panel Tools to integrate human rights in AI governance ? with Eliza Aspen (Amnesty International), Wanda Munoz (Feminist AI Research Network), Clara Neppel (Institute of Electrical and Electronics Engineers) & Elham Tabassi (National Institute of Standards & Technology)
11:45 a.m.: Lightning talk AI and human rights protection in Europe's new AI Act? by Gry Hasselbalch (European Union's International Outreach for a Human-Centric Approach to AI initiative)
1:15 p.m.: Panel Avenues of redress to protect human rights ? with Aziz Huq (Chicago Law School), Jake Okechukwu Effoduh (Toronto Metropolitan University), Fanny Hidvégi (Access Now) & Nele Roekens (Belgian National Human Rights Institution & Equality Body)
3:15 p.m.: Panel Creating momentum for human rights safeguards in international AI governance ? with Patrick Penninckx (Council of Europe), Karine Perset (OECD), Virginia Dignum (University of Umeå), Neema Lugangira (Government of Tanzania) & Cédric Wachholz (UNESCO)
5:15 p.m.: Closing remarks ? by Benjamin Prud'homme (Mila)
Flourish Ventures, an early-stage venture capital firm with purpose, today announced the appointment of Ravi Kaushik as Executive Director, Head of Asia Investments. Ravi will lead the global firm's fintech investments and portfolio management in...
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of information and communication technology solutions, today announced that it was honored with 2023 Climate...
During the second phase of the 135th China Import and Export Fair ("Canton Fair" or "the Fair"), a significant memorandum of cooperation was signed between the Fair and the Guangzhou Branch of the National Archives of Publications and Culture,...
Hikvision has released its full-year 2023 financial results, reporting a total revenue of RMB 89.34 billion, up 7.42% year-over-year. Net profit attributable to shareholders of the company was RMB 14.11 billion, achieving a year-over-year (YoY)...
DTEN, a leading provider of video conferencing solutions, is proud to announce that their flagship All-in-One solution, the DTEN D7X series, is now available to purchase in South Korea after it has successfully passed the rigorous certification...
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...